Left Atrial Appendage Closure: Technical Considerations of Endocardial Closure
Related Experiment Video
Updated: Dec 28, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Carlos E Sanchez1, Steven J Yakubov2, Anish Amin2
1Advanced Structural Heart Disease, OhioHealth Riverside Methodist Hospital, 3705 Olentangy River Road Suite 100, Columbus, OH 43214, USA.
Insights
Left atrial appendage closure (LAAC) offers a safe stroke prevention method for nonvalvular atrial fibrillation patients at high bleeding risk. Careful imaging and procedural steps are crucial for the WATCHMAN device
Area of Science:
- Cardiology
- Medical Devices
- Interventional Procedures
Background:
- Left atrial appendage closure (LAAC) is a key stroke prevention strategy for patients with nonvalvular atrial fibrillation (NVAF) who have a high bleeding risk.
- Oral anticoagulants are standard, but LAAC provides an alternative for specific patient populations.
- The WATCHMAN device is the sole LAAC device currently approved in the United States.
Purpose of the Study:
- To highlight the importance of multimodality imaging in defining left atrial appendage anatomy for LAAC.
- To emphasize the critical procedural steps for successful and safe LAAC using the WATCHMAN device.
- To underscore the necessity of precise anatomical assessment and device selection for optimal outcomes.
Main Methods:
- Utilizing transesophageal echocardiography and computed tomography angiography for detailed anatomical evaluation.
- Systematic assessment of the transseptal puncture site.
- Careful evaluation of left atrial appendage morphology and dimensions for appropriate device sizing.
- Thorough postdeployment assessment of the LAAC device.
Main Results:
- Multimodality imaging is increasingly vital for understanding anatomical implications on endocardial exclusion.
- A systematic approach to procedural steps ensures safety and efficacy.
- Proper device selection and placement are paramount for successful LAAC.
Conclusions:
- LAAC is a safe and effective stroke prevention therapy for NVAF patients with high bleeding risk.
- The WATCHMAN device requires meticulous procedural execution for optimal results.
- Comprehensive imaging and procedural assessment are essential for successful LAAC outcomes.
Abstract:
Left atrial appendage closure (LAAC) is a safe and effective therapy for the prevention of stroke in patients with nonvalvular atrial fibrillation and high bleeding risk with oral anticoagulants. Multimodality imaging with transesophageal echocardiography and computed tomography angiography to define the anatomy and its implications on endocardial exclusion is becoming increasingly important. The only LAAC device currently approved for clinical use in the United States is the WATCHMAN device. Systematic assessment of the transseptal crossing site, left atrial appendage anatomy, adequate device size selection, and device postdeployment evaluation is essential for the safety and efficacy of the procedure.

